private placement

Photo of a carnival ride that swings people in elevated chairs caught in motion
Biotech

Oruka spins out of Paragon with assets, public listing and cash

Oruka Therapeutics is jumping onto the biotech stage with a bang, going public via reverse merger with a $275 million private placement.
Max Bayer Apr 3, 2024 7:30am
MA

Avrobio's corporate tremor attracts Tectonic for reverse merger

Jan 30, 2024 3:24pm
sale for sale sell

BridgeBio bags $250M in stock sale before acoramidis submission

Sep 25, 2023 11:20am
cash money

SpringWorks enjoys double payday from GSK deal, $225M funding

Sep 7, 2022 10:49am
money and shares declining

Provention snags $60M to prep for diabetes drug launch

Jul 8, 2022 10:52am
Stanislas Veillet

Biophytis raises $12M for trials of aging disease duo

Oct 11, 2017 9:45am